Zelia Correa is a native of Brazil. After completing her medical, ophthalmology and fellowship training in retina, oncology and ophthalmic pathology, she practiced in Brazil for 10 years before joining UC in 2006. She is Professor of Ophthalmology, holds the Mary Knight Asbury Chair of Ocular Oncology and Pathology, and is Director of Ocular Oncology at UC. Dr. Correa was the first international participant of the American Academy of Ophthalmology’s (AAO) Leadership Development Program (LDP) in 2003. She subsequently developed a similar program in Latin America. She serves on the AAO’s Self-Assessment Committee, AAO’s EyeNet Editorial Board, AAO’s KTEF POWER editor, PAAO Board, Women in Ocular Oncology and Women in Retina Boards, International Council of Ophthalmology’s Professional Development Committee, and represents the PAAO in the AAO Council. Her research interests include prognostic testing and treatment of metastatic uveal melanoma, local treatments for retinoblastoma, and slow release drug delivery systems.